當(dāng)前位置：   首頁(yè) > 需求大廳

 >  特色服務(wù) 

我需要全國(guó)所有醫(yī)院的醫(yī)生信息表，告訴我哪里去查也可以   [更多]

我需要全國(guó)各醫(yī)院的銷售數(shù)據(jù)，尋找可以長(zhǎng)期提供醫(yī)院銷售數(shù)據(jù)的合作者，醫(yī)院銷售數(shù)據(jù)要求具體到某個(gè)醫(yī)院并且數(shù)據(jù)真實(shí)可靠。 如果能長(zhǎng)期提供該數(shù)據(jù)的，請(qǐng)投稿，具體價(jià)格等事宜單獨(dú)聯(lián)系。   [更多]

尋找可以提供醫(yī)療器械銷售數(shù)據(jù)的服務(wù)。有相關(guān)渠道的朋友在下方投稿。具體的合作方式和價(jià)格，我會(huì)主動(dòng)聯(lián)系您再詳細(xì)談。   [更多]

當(dāng)心血管疾病（心臟病或中風(fēng)）確診后，醫(yī)生會(huì)提供治療建議，但病人的決定是至關(guān)重要的。美國(guó)心臟協(xié)會(huì)（AHA）與 以病人為中心的成果研究所（PCORI）合作，網(wǎng)絡(luò)征集文章。你可以是患者，社區(qū)志愿者，家庭成員或任何人，只要你有這方面的親身經(jīng)驗(yàn)。根據(jù)你的情況來(lái)闡述患者的治療決策是怎樣做出的，例如：對(duì)壽命的影響，對(duì)生活質(zhì)量的影響，費(fèi)用，或其他？同時(shí)關(guān)心過(guò)程的完整性，時(shí)間，等等。。。 “請(qǐng)于2016年6月9日之前將稿件上傳到：https://www.innocentive.com/ar/workspace/challengeDetail?challenge=9933835“ THE CHALLENGE Treatment of heart disease and stroke often requires patients and their families to make many decisions on how to move forward after a cardiac event. Specifically, AHA and PCORI are interested in learning about the “decisional dilemmas” you face – your insights will help guide future research to improve heart health. Based on the input from you and others in the patient and caregiver community, we will identify important concerns and use the perspectives to target research towards what matters most. Despite multiple available treatment options that your physician may describe, you may not always know which option is right/best for you. Tell us about the most difficult decision that you or your family faced when evaluating treatment options for heart disease or stroke. In addition, we would like to understand more about what you considered most important when making this choice or decision. Please pick your top three choices and tell us why they are important to you and your family: Side effects of the treatment Complexity of treatment plan Difficulty in adhering to a treatment Impact on my quality of life Potential to prolong my life Whether the best option for me is selected based on research of people similar to me (personal characteristics such as my age, race and gender) Whether my family history and genetic makeup would influence the effectiveness of a given option Whether a trusted source recommended a specific option The financial impact of the options for me and my family Other:________ Any submission should address the following Submission Requirements: The submission can be from anyone (patient, caregiver, family member, or other)   [更多]

頭孢地尼顆粒JX20100254的具體標(biāo)準(zhǔn)，價(jià)格可商議   [更多]

防粘連產(chǎn)品屬于三類醫(yī)療器械，現(xiàn)需行業(yè)終端銷售數(shù)據(jù)、市場(chǎng)分布等信息。價(jià)格另議。   [更多]

求助“Acetylsalicylic acid ”《 EP8.8 》的藥典標(biāo)準(zhǔn)一份   [更多]

具體要求： 以1000元求購(gòu)一個(gè)易邁得會(huì)員賬號(hào)，保證在1年之內(nèi)可進(jìn)行中標(biāo)數(shù)據(jù)信息的有效查詢。 PS:請(qǐng)不要用賬號(hào)密碼直接投標(biāo)，請(qǐng)先溝通之后再給賬號(hào)密碼。   [更多]

求購(gòu)“Ranitidine Hydrochloride”《 BP2015 》的藥典標(biāo)準(zhǔn)一份.   [更多]

需要的是阿立哌唑溶液劑的藥典標(biāo)準(zhǔn)，是溶液劑的藥典標(biāo)準(zhǔn)，?。。。。?！不要原料藥的標(biāo)準(zhǔn)。需查找美國(guó)、歐洲、日本的最新版本的藥典，如沒(méi)有收錄請(qǐng)附目錄證明。   [更多]